Catumaxomab monoclonal antibody drug. Targets CD3 and EpCAM. Used in treatment of malignant ascites. Generic name and stylized antibody representation


Catumaxomab monoclonal antibody drug. Targets CD3 and EpCAM. Used in treatment of malignant ascites. Generic name and stylized antibody representation.


Size: 6802px × 2302px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: adhesion, antibody, ascites, biological, biosimilar, biotech, biotechnology, cancer, catumaxomab, cavity, cd3, cell, disease, drug, epcam, epithelial, fluid, hybrid, immunoglobulin, immunology, infusion, injection, inn, mab, malignant, metastasis, molecule, monoclonal, nomenclature, oncology, peptide, peritoneal, protein, rat-mouse, tumor